Design, Construction, and In Vitro Analyses of Multivalent Antibodies

作者: Kathy Miller , Gloria Meng , Jun Liu , Amy Hurst , Vanessa Hsei

DOI: 10.4049/JIMMUNOL.170.9.4854

关键词:

摘要: Some Abs are more efficacious after being cross-linked to form dimers or multimers, presumably as a result of binding and clustering surface target either amplify diversify cellular signaling. To improve the therapeutic potency these types Abs, we designed generated that express tandem Fab repeats with aim mimicking Abs. The versatile design system enables creation series multivalent human IgG Ab forms including tetravalent IgG1, F(ab')2, linear multimers three four consecutively linked Fabs. multimerized cell receptors HER2, death receptor 5, CD20, than their parent mAbs in triggering antitumor responses, indicating they could be useful both reagents for study well novel therapeutics.

参考文章(67)
D. R. Anderson, A. Grillo-López, C. Varns, K. S. Chambers, N. Hanna, TARGETED ANTI-CANCER THERAPY USING RITUXIMAB, A CHIMAERIC ANTI-CD20 ANTIBODY (IDEC-C2B8) IN THE TREATMENT OF NON-HODGKIN'S B-CELL LYMPHOMA Biochemical Society Transactions. ,vol. 25, pp. 705- 708 ,(1997) , 10.1042/BST0250705
Thomas A. Morton, David G. Myszka, Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods in Enzymology. ,vol. 295, pp. 268- 294 ,(1998) , 10.1016/S0076-6879(98)95044-3
G Koopman, CP Reutelingsperger, GA Kuijten, RM Keehnen, ST Pals, MH van Oers, Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. ,vol. 84, pp. 1415- 1420 ,(1994) , 10.1182/BLOOD.V84.5.1415.1415
Bruce A. Chabner, Saul A. Schepartz, Michael R. Grever, The National Cancer Institute: cancer drug discovery and development program. Seminars in Oncology. ,vol. 19, pp. 622- 638 ,(1992) , 10.5555/URI:PII:009377549290032V
C. M Gorman, D. R Gies, G Mccray, Transient production of proteins using an adenovirus transformed cell line DNA and protein engineering techniques. ,vol. 2, pp. 3- 10 ,(1990)
E.L. Sievers, F.R. Appelbaum, R.T. Spielberger, S.J. Forman, D. Flowers, F.O. Smith, K. Shannon-Dorcy, M.S. Berger, I.D. Bernstein, Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. ,vol. 93, pp. 3678- 3684 ,(1999) , 10.1182/BLOOD.V93.11.3678.411K24_3678_3684
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Kwok S. Kan, Valerie A. Anderson, Weng S. Leong, Andrew M. Smith, Andrew T. Worth, George T. Stevenson, Thioether-Bonded Constructs of Fab′γ and Fcγ Modules Utilizing Differential Reduction of Interchain Disulfide Bonds The Journal of Immunology. ,vol. 166, pp. 1320- 1326 ,(2001) , 10.4049/JIMMUNOL.166.2.1320
Yoram Reiter, Recombinant immunotoxins in targeted cancer cell therapy Advances in Cancer Research. ,vol. 81, pp. 93- 124 ,(2001) , 10.1016/S0065-230X(01)81003-4